BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12039701)

  • 1. Does GH replacement therapy in adult GH-deficient patients result in recurrence or increase in size of pituitary tumours?
    Hatrick AG; Boghalo P; Bingham JB; Ayres AB; Sonksen PH; Russell-Jones DL
    Eur J Endocrinol; 2002 Jun; 146(6):807-11. PubMed ID: 12039701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GH replacement in 1034 growth hormone deficient hypopituitary adults: demographic and clinical characteristics, dosing and safety.
    Abs R; Bengtsson BA; Hernberg-Stâhl E; Monson JP; Tauber JP; Wilton P; Wüster C
    Clin Endocrinol (Oxf); 1999 Jun; 50(6):703-13. PubMed ID: 10468941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing progression of non-functioning pituitary adenomas in hypopituitarism patients with and without long-term GH replacement therapy.
    Olsson DS; Buchfelder M; Schlaffer S; Bengtsson BA; Jakobsson KE; Johannsson G; Nilsson AG
    Eur J Endocrinol; 2009 Nov; 161(5):663-9. PubMed ID: 19734242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Replacement therapy with growth hormone and pituitary tumor recurrence: the relevance of the problem.
    Losa M; Gatti E; Rossini A; Lanzi R
    J Endocrinol Invest; 2008 Sep; 31(9 Suppl):75-8. PubMed ID: 19020392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline characteristics and response to 2 years of growth hormone (GH) replacement of hypopituitary patients with GH deficiency due to adult-onset craniopharyngioma in comparison with patients with nonfunctioning pituitary adenoma: data from KIMS (Pfizer International Metabolic Database).
    Verhelst J; Kendall-Taylor P; Erfurth EM; Price DA; Geffner M; Koltowska-Häggström M; Jönsson PJ; Wilton P; Abs R
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4636-43. PubMed ID: 15928246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of primary cancers and intracranial tumour recurrences in GH-treated and untreated adult hypopituitary patients: analyses from the Hypopituitary Control and Complications Study.
    Child CJ; Conroy D; Zimmermann AG; Woodmansee WW; Erfurth EM; Robison LL
    Eur J Endocrinol; 2015 Jun; 172(6):779-90. PubMed ID: 25810462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor Recurrence or Regrowth in Adults With Nonfunctioning Pituitary Adenomas Using GH Replacement Therapy.
    van Varsseveld NC; van Bunderen CC; Franken AA; Koppeschaar HP; van der Lely AJ; Drent ML
    J Clin Endocrinol Metab; 2015 Aug; 100(8):3132-9. PubMed ID: 26057181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth Hormone Therapy Does Not Increase the Risk of Craniopharyngioma and Nonfunctioning Pituitary Adenoma Recurrence.
    Losa M; Castellino L; Pagnano A; Rossini A; Mortini P; Lanzi R
    J Clin Endocrinol Metab; 2020 May; 105(5):. PubMed ID: 32112101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database.
    Abs R; Mattsson AF; Bengtsson BA; Feldt-Rasmussen U; Góth MI; Koltowska-Häggström M; Monson JP; Verhelst J; Wilton P;
    Growth Horm IGF Res; 2005 Oct; 15(5):349-59. PubMed ID: 16168692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Night sleep EEG and daytime sleep propensity in adult hypopituitary patients with growth hormone deficiency before and after six months of growth hormone replacement.
    Schneider HJ; Oertel H; Murck H; Pollmächer T; Stalla GK; Steiger A
    Psychoneuroendocrinology; 2005 Jan; 30(1):29-37. PubMed ID: 15358440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression of pituitary tumours: impact of GH secretory status and long-term GH replacement therapy.
    Gasco V; Caputo M; Cambria V; Beccuti G; Caprino MP; Ghigo E; Maccario M; Grottoli S
    Endocrine; 2019 Feb; 63(2):341-347. PubMed ID: 30341707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease.
    Fernholm R; Bramnert M; Hägg E; Hilding A; Baylink DJ; Mohan S; Thorén M
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4104-12. PubMed ID: 11095440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour surveillance imaging in patients with extrapituitary tumours receiving growth hormone replacement.
    Chung TT; Drake WM; Evanson J; Walker D; Plowman PN; Chew SL; Grossman AB; Besser GM; Monson JP
    Clin Endocrinol (Oxf); 2005 Sep; 63(3):274-9. PubMed ID: 16117814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of GH substitution therapy in deficient adults on the recurrence rate of hormonally inactive pituitary adenomas: a case control study.
    Buchfelder M; Kann PH; Wüster C; Tuschy U; Saller B; Brabant G; Kleindienst A; Nomikos P;
    Eur J Endocrinol; 2007 Aug; 157(2):149-56. PubMed ID: 17656592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative growth hormone (GH) peak values during a GH releasing peptide-2 test reflect the severity of hypopituitarism and the postoperative recovery of GH secretion in patients with non-functioning pituitary adenomas.
    Soga A; Fukuda I; Kobayashi S; Tahara S; Morita A; Sugihara H
    Endocr J; 2020 Feb; 67(2):167-175. PubMed ID: 31776295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of GH replacement in hypopituitary patients with nonirradiated pituitary and peripituitary tumours.
    Chung TT; Evanson J; Walker D; Akker SA; Besser GM; Monson JP; Grossman AB; Drake WM
    Clin Endocrinol (Oxf); 2008 Jun; 68(6):965-9. PubMed ID: 18031317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspects of growth hormone deficiency and replacement in elderly hypopituitary adults.
    Feldt-Rasmussen U; Wilton P; Jonsson P; ;
    Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S51-8. PubMed ID: 15135778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative growth hormone dynamics in clinically nonfunctioning pituitary adenoma.
    Kobayashi N; Yamaguchi-Okada M; Horiguchi K; Fukuhara N; Nishioka H; Yamada S
    Endocr J; 2018 Aug; 65(8):827-832. PubMed ID: 29910227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fractures in pituitary adenoma patients from the Dutch National Registry of Growth Hormone Treatment in Adults.
    van Varsseveld NC; van Bunderen CC; Franken AA; Koppeschaar HP; van der Lely AJ; Drent ML
    Pituitary; 2016 Aug; 19(4):381-90. PubMed ID: 27048484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of growth hormone on pituitary tumour growth.
    Herring R; Russell-Jones D
    Curr Opin Endocrinol Diabetes Obes; 2010 Aug; 17(4):365-8. PubMed ID: 20498595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.